NICE Ltd. NICE
93.73 USD -2.95 (-3.05%)
At closeNov 10, 2026, 5:33 PM EST
93.73 0.00 0.00%
After hours · Nov 10, 5:33 PM ET
92.67 Day range 96.29
83.10 52-week range 136.53
- YTD
- -17.08%
- 1 year
- -26.76%
News
seekingalpha.com NICE Ltd. Is Growing While The Market Stays Skeptical NICE Ltd. maintains a Strong Buy rating, supported by resilient revenue growth, robust AI ARR up 46%, and an expanding CXone backlog. Despite margin compression and integration costs, NICE reiterates…
benzinga.com RBC Capital Maintains Outperform on NICE, Lowers Price Target to $130 RBC Capital analyst Rishi Jaluria maintains NICE (NASDAQ:NICE) with a Outperform and lowers the price target from $145 to $130.- benzinga.com Citizens Maintains Market Outperform on NICE, Lowers Price Target to $158 Citizens analyst Patrick Walravens maintains NICE (NASDAQ:NICE) with a Market Outperform and lowers the price target from $170 to $158.
marketbeat.com NiCE Q3 Earnings Call Highlights NiCE NASDAQ: NICE reported third-quarter revenue and adjusted earnings above the high end of its guidance, while management said it is taking steps to improve cloud growth and streamline operations…
seekingalpha.com NICE Ltd. (NICE) Q3 2026 Earnings Call Transcript NICE Ltd. (NICE) Q3 2026 Earnings Call Transcript
zacks.com Nice (NICE) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates Although the revenue and EPS for Nice (NICE) give a sense of how its business performed in the quarter ended September 2026, it might be worth considering how some key metrics compare with Wall…
benzinga.com NICE Q3 2026 Earnings Call Transcript NICE (NASDAQ:NICE) reported third-quarter financial results on Wednesday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by…
globenewswire.com Rhythm Pharmaceuticals Announces NICE Guidance for IMCIVREE® (Setmelanotide) Updated to Include Adults Living with Bardet-Biedl Syndrome -- Expanded guidance based on additional evidence demonstrating the benefits of IMCIVREE in adults living with Bardet-Biedl syndrome -- BOSTON, Nov. 04, 2026 (GLOBE NEWSWIRE) -- Rhythm…
benzinga.com 12 Information Technology Stocks Moving In Wednesday's Pre-Market Session Gainers Helport AI (NASDAQ:HPAI) shares moved upwards by 40.0% to $0.34 during Wednesday's pre-market session. The market value of their outstanding shares is at $9.0 million. CPS Technologies…
benzinga.com NICE Q3 Adj. EPS $2.84 Beats $2.77 Estimate, Sales $790.741M Beat $785.925M Estimate NICE (NASDAQ:NICE) reported quarterly earnings of $2.84 per share which beat the analyst consensus estimate of $2.77 by 2.16 percent. This is a 10.69 percent decrease over earnings of $3.18 per share…
businesswire.com NiCE Exceeds Revenue and EPS Guidance Ranges, Reporting 8% Year-Over-Year Revenue Growth in Third Quarter 2026 HOBOKEN, N.J.--(BUSINESS WIRE)--NiCE (NASDAQ: NICE) today announced results for the third quarter ended September 30, 2026, as compared to the corresponding period of the previous year. Third Quarter…
benzinga.com This Nice Analyst Turns Bullish; Here Are Top 3 Upgrades For Wednesday Wall Street analysts upgraded Grocery Outlet, NICE and Pinnacle Financial Partners; targets are $15, $150 and $118, respectively.
benzinga.com Oppenheimer Upgrades NICE to Outperform, Announces $150 Price Target Oppenheimer analyst Timothy Horan upgrades NICE (NASDAQ:NICE) from Perform to Outperform and announces $150 price target.
benzinga.com RBC Capital Maintains Outperform on NICE, Raises Price Target to $145 RBC Capital analyst Rishi Jaluria maintains NICE (NASDAQ:NICE) with a Outperform and raises the price target from $130 to $145.
benzinga.com DA Davidson Maintains Buy on NICE, Raises Price Target to $115 DA Davidson analyst Clark Wright maintains NICE (NASDAQ:NICE) with a Buy and raises the price target from $110 to $115.- benzinga.com NICE Raises FY2026 Adj EPS Guidance from $10.98-$11.18 to $11.06-$11.26 vs $11.10 Est; Affirms FY2026 Sales Guidance of $3.170B-$3.190B vs $3.179B Est NICE (NASDAQ:NICE) raises FY2026 Adj EPS guidance from $10.98-$11.18 to $11.06-$11.26 vs $11.10 analyst estimate. Affirms FY2026 sales outlook from $3.170 billion-$3.190 billion to $3.170…
- benzinga.com NICE Sees Q3 Adj EPS $2.73-$2.83 vs $2.79 Est; Sees Sales $780.000M-$790.000M vs $795.481M Est NICE (NASDAQ:NICE) is looking for Q3 Adj EPS of $2.73-$2.83 vs $2.79 analyst estimate. sees sales of $780.000 million-$790.000 million vs $795.481 million analyst estimate.
- benzinga.com NICE Q2 Adj. EPS $2.70 Beats $2.64 Estimate, Sales $782.293M Beat $766.507M Estimate NICE (NASDAQ:NICE) reported quarterly earnings of $2.70 per share which beat the analyst consensus estimate of $2.64 by 2.27 percent. This is a 10.3 percent decrease over earnings of $3.01 per share…
benzinga.com RingCentral Stock is Jumping Today: What's Going On? RingCentral shares are soaring Friday after the company posted Q2 earnings beat and raised its full-year outlook.- benzinga.com NiCE Expands Collaboration With RingCentral For NiCE To Resell RingCentral's Unified Communications As A Service Solution RingEXTM NiCE (NASDAQ:NICE) today announced a significant expansion of its long-standing partnership with RingCentral, Inc. (NYSE:RNG), a global leader in AI-powered customer engagement. Under a new…
- benzinga.com Morgan Stanley Downgrades NICE to Equal-Weight, Lowers Price Target to $111 Morgan Stanley analyst Elizabeth Porter downgrades NICE (NASDAQ:NICE) from Overweight to Equal-Weight and lowers the price target from $130 to $111.
benzinga.com TTEC Digital Receives NiCE 360 VISION Partner Program's Platinum Partner Status TTEC, a leading global consulting, technology, and managed services company delivering solutions at the intersection of data, AI, and customer experience (CX), today announced that TTEC Digital has
benzinga.com This NICE Analyst Turns Bullish; Here Are Top 4 Upgrades For Thursday Wall Street analysts upgraded REXR, NICE, BXP, and EPRT stocks and lowered price targets. Check out other analysts' views. Photo by Shutterstock.
benzinga.com DA Davidson Upgrades NICE to Buy, Maintains Price Target to $110 DA Davidson analyst Clark Wright upgrades NICE (NASDAQ:NICE) from Neutral to Buy and maintains the price target from $110 to $110.- benzinga.com RBC Capital Reiterates Outperform on NICE, Maintains $130 Price Target RBC Capital analyst Rishi Jaluria reiterates NICE (NASDAQ:NICE) with a Outperform and maintains $130 price target.
- benzinga.com Wedbush Maintains Neutral on NICE, Lowers Price Target to $100 Wedbush analyst Dan Ives maintains NICE (NASDAQ:NICE) with a Neutral and lowers the price target from $120 to $100.
- benzinga.com Cantor Fitzgerald Reiterates Neutral on NICE, Maintains $104 Price Target Cantor Fitzgerald analyst Thomas Blakey reiterates NICE (NASDAQ:NICE) with a Neutral and maintains $104 price target.
- benzinga.com BluIP Announces Expanded Go-To-Market Partnership With NiCE To Deliver Unified Communications As A Service And Contact Center As A Service Solution Integrated Cloud PBX and Contact Center Platform Extends AI, Analytics, and Operational Intelligence Across the Entire OrganizationLAS VEGAS, June 8, 2026 /PRNewswire/ -- BluIP, a leading provider of…
- benzinga.com DNB Bank Partners With NICE Actimize And Infosys To Modernize Financial Crime Operations On X-Sight SaaS Platform This transformation program is being delivered in strategic collaboration with Infosys to address the changing fraud and regulatory risk landscapeNICE Actimize, a NiCE (NASDAQ:NICE) business, today…
benzinga.com Morgan Stanley Maintains Overweight on NICE, Lowers Price Target to $130 Morgan Stanley analyst Hamza Fodderwala maintains NICE (NASDAQ:NICE) with a Overweight and lowers the price target from $148 to $130.- benzinga.com Citigroup Maintains Neutral on NICE, Lowers Price Target to $100 Citigroup analyst Tyler Radke maintains NICE (NASDAQ:NICE) with a Neutral and lowers the price target from $119 to $100.
- benzinga.com RBC Capital Maintains Outperform on NICE, Lowers Price Target to $130 RBC Capital analyst Rishi Jaluria maintains NICE (NASDAQ:NICE) with a Outperform and lowers the price target from $150 to $130.
- benzinga.com Citizens Maintains Market Outperform on NICE, Lowers Price Target to $170 Citizens analyst Patrick Walravens maintains NICE (NASDAQ:NICE) with a Market Outperform and lowers the price target from $200 to $170.
benzinga.com Earnings Scheduled For May 6, 2026 
benzinga.com 12 Information Technology Stocks Moving In Wednesday's Intraday Session 
benzinga.com Transcript: NICE Q1 2026 Earnings Conference Call - benzinga.com 12 Information Technology Stocks Moving In Wednesday's Pre-Market Session
benzinga.com What's Going On With NICE Stock Wednesday? NICE beats Q1 2026 expectations with $2.64 EPS and $768.6M in sales. Cloud revenue up 14.6% as AI momentum drives growth.- benzinga.com NICE Raises FY2026 Adj EPS Guidance from $10.85-$11.05 to $10.98-$11.18 vs $10.94 Est; Affirms FY2026 Sales Guidance of $3.170B-$3.190B vs $3.192B Est NICE (NASDAQ:NICE) raises FY2026 Adj EPS guidance from $10.85-$11.05 to $10.98-$11.18 vs $10.94 analyst estimate. Affirms FY2026 sales outlook from $3.170 billion-$3.190 billion to $3.170…
- benzinga.com NICE Sees Q2 Adj EPS $2.60-$2.70 vs $2.65 Est; Sees Sales $761.000M-$771.000M vs $780.640M Est NICE (NASDAQ:NICE) is looking for Q2 Adj EPS of $2.60-$2.70 vs $2.65 analyst estimate. sees sales of $761.000 million-$771.000 million vs $780.640 million analyst estimate.
- benzinga.com NICE Q1 Adj. EPS $2.64 Beats $2.52 Estimate, Sales $768.617M Beat $764.239M Estimate NICE (NASDAQ:NICE) reported quarterly earnings of $2.64 per share which beat the analyst consensus estimate of $2.52 by 4.76 percent. This is a 8.01 percent decrease over earnings of $2.87 per share…
benzinga.com Global Business Travel Group Posts Upbeat Q1 Results, Joins Cabaletta Bio, Aura Biosciences And Other Big Stocks Moving Higher On Monday Global Business Travel Group Inc (GBTG), a NYSE-listed company, saw its stock rise 57% on Monday after reporting better-than-expected financial results. Other top gainers included companies like…- benzinga.com 12 Information Technology Stocks Moving In Monday's Pre-Market Session
benzinga.com Boyd Gaming Posts Downbeat Q1 Results, Joins Coursera, Evotec And Other Big Stocks Moving Lower In Friday's Pre-Market Session U.S. stock futures mixed, Dow down 100 points. Boyd Gaming Corp shares drop 6.1% after worse-than-expected Q1 results and $500M buyback plan.- benzinga.com Citigroup Downgrades NICE to Neutral, Lowers Price Target to $119 Citigroup analyst Tyler Radke downgrades NICE (NASDAQ:NICE) from Buy to Neutral and lowers the price target from $184 to $119.
benzinga.com NICE Stock: A Deep Dive Into Analyst Perspectives (5 Ratings) 
benzinga.com RBC Capital Maintains Outperform on NICE, Lowers Price Target to $150 RBC Capital analyst Rishi Jaluria maintains NICE (NASDAQ:NICE) with a Outperform and lowers the price target from $175 to $150.- benzinga.com 12 Information Technology Stocks Moving In Thursday's Intraday Session
benzinga.com Deere Posts Upbeat Q4 Earnings, Joins Herbalife, Omnicom Group, Occidental Petroleum And Other Big Stocks Moving Higher On Thursday - benzinga.com Earnings Scheduled For February 19, 2026